Reference
Loeb S, et al. Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma. JAMA: the Journal of the American Medical Association 313: 2449-55, No. 24, 23 Jun 2015. Available from: URL: http://doi.org/10.1001/jama.2015.6604
Rights and permissions
About this article
Cite this article
PDE5 inhibitors: increased risk of malignant melanoma?. Reactions Weekly 1559, 8 (2015). https://doi.org/10.1007/s40278-015-3197-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-3197-7